Reported 1,634,815 shares, up 958,197 (141.6%) from the prior quarter.
Reported value 209.7%; share count 141.6% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 621000 |
| 2022-03-31 | 532000 |
| 2022-06-30 | 2249000 |
| 2022-09-30 | 2641000 |
| 2022-12-31 | 2211364 |
| 2023-03-31 | 5473840 |
| 2023-06-30 | 16953031 |
| 2023-09-30 | 11633979 |
| 2023-12-31 | 1024674 |
| 2024-03-31 | 609665 |
| 2024-06-30 | 204977 |
| 2024-09-30 | 552889 |
| 2024-12-31 | 2658025 |
| 2025-03-31 | 3695843 |
| 2025-06-30 | 5027072 |
| 2025-09-30 | 7746768 |
| 2025-12-31 | 10280323 |
| 2026-03-31 | 10298633 |
| 2026-06-30 | 709477 |
| 2026-09-30 | 1294459 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 246,095 | +111,978 (83.5%) | < 0.01% | $1,294,459 | 2026-11-13 | |
| Q2 2026 | Reduced | 134,117 | -2,612,185 (-95.1%) | < 0.01% | $709,477 | 2026-08-13 | |
| Q1 2026 | Reduced | 2,746,302 | -669,088 (-19.6%) | < 0.01% | $10,298,633 | 2026-05-15 | |
| Q4 2025 | Reduced | 3,415,390 | -661,856 (-16.2%) | < 0.01% | $10,280,323 | 2026-02-13 | |
| Q3 2025 | Added | 4,077,246 | +537,054 (15.2%) | < 0.01% | $7,746,768 | 2025-11-14 | |
| Q2 2025 | Added | 3,540,192 | +1,124,608 (46.6%) | < 0.01% | $5,027,072 | 2025-08-15 | |
| Q1 2025 | Added | 2,415,584 | +1,343,800 (125.4%) | < 0.01% | $3,695,843 | 2025-05-15 | |
| Q4 2024 | Added | 1,071,784 | +591,011 (122.9%) | < 0.01% | $2,658,025 | 2025-02-14 | |
| Q3 2024 | Added | 480,773 | +294,430 (158.0%) | < 0.01% | $552,889 | 2024-11-14 | |
| Q2 2024 | Reduced | 186,343 | -305,323 (-62.1%) | < 0.01% | $204,977 | 2024-08-14 | |
| Q1 2024 | Reduced | 491,666 | -484,213 (-49.6%) | < 0.01% | $609,665 | 2024-05-15 | |
| Q4 2023 | Reduced | 975,879 | -722,512 (-42.5%) | < 0.01% | $1,024,674 | 2024-02-13 | |
| Q3 2023 | Added | 1,698,391 | +63,576 (3.9%) | < 0.01% | $11,633,979 | 2023-11-15 | |
| Q2 2023 | Added | 1,634,815 | +958,197 (141.6%) | < 0.01% | $16,953,031 | 2023-08-14 | |
| Q1 2023 | Added | 676,618 | +536,214 (381.9%) | < 0.01% | $5,473,840 | 2023-05-15 | |
| Q4 2022 | Reduced | 140,404 | -27,408 (-16.3%) | < 0.01% | $2,211,364 | 2023-02-14 | |
| Q3 2022 | Added | 167,812 | +6,702 (4.2%) | < 0.01% | $2,641,000 | 2022-11-14 | |
| Q2 2022 | Added | 161,110 | +130,171 (420.7%) | < 0.01% | $2,249,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 30,939 | -11,806 (-27.6%) | < 0.01% | $532,000 | 2022-05-13 | |
| Q4 2021 | Added | 42,745 | +10,303 (31.8%) | < 0.01% | $621,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
161 managers reported ACLARIS THERAPEUTICS INC for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | Added | 7,637,868 | +265,267 | 0.02% | $79,204,691 | 10 qtrs |
| BlackRock Inc | Added | 5,594,173 | +478,800 | < 0.01% | $58,011,574 | 30 qtrs |
| RA CAPITAL MANAGEMENT L P | Unchanged | 4,398,453 | 0 | 0.86% | $45,611,958 | 6 qtrs |
| Rock Springs Capital Management LP | Unchanged | 3,961,849 | 0 | 0.98% | $41,084,374 | 31 qtrs |
| Bain Capital Life Sciences Investors LLC | Unchanged | 3,400,000 | 0 | 3.63% | $35,258,000 | 2 qtrs |
| BVF INC IL | Unchanged | 3,360,941 | 0 | 0.97% | $34,852,958 | 9 qtrs |
| VANGUARD GROUP INC | Added | 3,329,564 | +137,138 | < 0.01% | $34,527,578 | 31 qtrs |
| BRAIDWELL LP | Reduced | 2,901,194 | -367,900 | 0.98% | $30,085,382 | 3 qtrs |
| Foresite Capital Management IV LLC | Unchanged | 2,808,034 | 0 | 14.32% | $29,119,313 | 12 qtrs |
| CITADEL ADVISORS LLC | Reduced | 2,613,074 | -494,690 | < 0.01% | $27,097,577 | 28 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 14, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 1,616,558
- Shared
- 1,049
- None
- 17,208
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.